Clinical Trial: CAR T Cells in Mesothelin-Expressing Breast Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Breast Cancer
Study Type: INTERVENTIONAL
Official Title: Phase 1, Adaptive-design Trial of Human Chimeric Antigen Receptor Modified T Cells in Patients With Mesothelin Expressing Breast Cancer
Brief Summary:
Phase 1 - Safety and Proof of Concept
Read more